Holen Sie sich die Stockscreener-App
20.98
2.74%
-0.57
Handel nachbörslich:
20.98
Schlusskurs vom Vortag:
$21.55
Offen:
$21.55
24-Stunden-Volumen:
1.35M
Relative Volume:
0.88
Marktkapitalisierung:
$1.81B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
33.30
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
-4.38%
1M Leistung:
-26.25%
6M Leistung:
-3.76%
1J Leistung:
-4.81%
1-Tages-Spanne:
$20.89
$21.75
1-Wochen-Bereich:
$20.75
$22.45
52-Wochen-Spanne:
$17.98
$28.75
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
20.96 | 1.86B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
284.49 | 252.65B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
77.91 | 97.99B | 402.11B | 1.73B | 7.81B | 1.3789 |
|
CI
Cigna Group
|
287.49 | 77.65B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
336.04 | 72.89B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
179.00 | 21.10B | 126.36B | 1.30B | 1.55B | 10.67 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report - Bluefield Daily Telegraph
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report - GlobeNewswire Inc.
Progyny Adjusts Evaluation Amid Strong Growth and Financial Resilience - Markets Mojo
Progyny, Inc. $PGNY Shares Purchased by Principal Financial Group Inc. - MarketBeat
(PGNY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Progyny, Inc. (NASDAQ:PGNY) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Progyny Breaks Below 200-Day Moving AverageNotable for PGNY - Nasdaq
Progyny’s Financial Milestone: Upcoming Report to Set Direction - AD HOC NEWS
Progyny, Inc. $PGNY Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Sees Significant Decline in Short Interest - MarketBeat
Assessing Progyny (PGNY) Valuation After Recent Share Pullback And 3‑Month Rebound - Yahoo Finance
(PGNY) Risk Channels and Responsive Allocation - Stock Traders Daily
105,000 Shares in Progyny, Inc. $PGNY Acquired by Hussman Strategic Advisors Inc. - MarketBeat
Progyny, Inc. (PGNY) Investor Outlook: Analyzing a Promising 24.43% Potential Upside in Healthcare Plans - DirectorsTalk Interviews
Kornitzer Capital Management Inc. KS Sells 85,000 Shares of Progyny, Inc. $PGNY - MarketBeat
Progyny Inc (NASDAQ:PGNY) Combines Strong Fundamentals with Bullish Technical Setup - ChartMill
Published on: 2026-01-27 11:06:26 - baoquankhu1.vn
US Market Recap: Why is Progyny Inc stock going downMarket Movers & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Bull Run: Is Progyny Inc forming a bullish divergenceMarket Activity Report & Precise Swing Trade Alerts - baoquankhu1.vn
Progyny, Inc. (PGNY) supported by analysts as earnings visibility improves - MSN
Hedge Fund Bets: How do insiders feel about ProShares Trust ProShares Ultra SemiconductorsJuly 2025 Price Swings & Expert Approved Trade Ideas - baoquankhu1.vn
Wall Street Recap: What analysts say about Progyny Inc stockTrade Risk Assessment & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Progyny price target raised to $35 from $30 at BTIG - Yahoo Finance
SG Americas Securities LLC Cuts Stock Position in Progyny, Inc. $PGNY - MarketBeat
Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves - Insider Monkey
Progyny Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily
ETF Watch: Is Progyny Inc stock technically oversold2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Progyny (PGNY) Stock Rises on Analyst Upgrade to Market Outperform | 2026 OutlookNews and Statistics - IndexBox
Progyny (PGNY) Stock Is Up, What You Need To Know - Finviz
Progyny sees IBD RS rating climb to 77 - MSN
Forecasting The Future: 6 Analyst Projections For Progyny - Benzinga
Progyny (NASDAQ:PGNY) Upgraded by Citizens Jmp to "Market Outperform" Rating - MarketBeat
Citizens Upgrades Progyny (PGNY) - Nasdaq
PGNY Stock Rating Upgraded by Citizens to Market Outperform | PG - GuruFocus
Progyny stock rating upgraded by Citizens on strong retention rates - Investing.com Canada
This Intel Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Progyny president’s employment to end December 2025 - MSN
Short Interest in Progyny, Inc. (NASDAQ:PGNY) Declines By 23.3% - MarketBeat
(PGNY) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Can Progyny’s (PGNY) Modest Guidance Raise Redefine Its Demand Resilience Narrative? - Yahoo Finance
Stock Picks for 2026: e.l.f. Beauty to Buy, American Woodmark & Progyny to SellNews and Statistics - IndexBox
Pullback Watch: Why is Progyny Inc stock going downJuly 2025 Levels & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Progyny Inc (PGNY) Shares Gap Down to $24.7608 on Jan 15 - GuruFocus
Stocks Flashing Renewed Technical Strength: Progyny - Investor's Business Daily
Aug Setups: Is Progyny Inc impacted by rising rates2025 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Regeneron (REGN) and Progyny (PGNY) - The Globe and Mail
Progyny (NASDAQ:PGNY) Reaches New 1-Year HighTime to Buy? - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Progyny Stock (-11%) : JPM Conference Growth Narrative Fails to Impress - Trefis
Progyny (NASDAQ:PGNY) Shares Down 5.9%Time to Sell? - MarketBeat
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - 富途牛牛
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.74%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):